ANI Pharma (ANIP) Tops Q4 EPS by 8c, Revenues Beat; Offers FY19 EPS/Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to ANI Pharma (ANIP) Tops Q4 EPS by 8c, Revenues Beat; Offers FY19 EPS/Revenue Outlook

ANI Pharmaceuticals Reports Record Full Year and Fourth Quarter 2018 Results and Provides 2019 Guidance

February 27, 2019 8:30 AM EST

BAUDETTE, Minn., Feb. 27, 2019 /PRNewswire/ --

For the full year ended December 31, 2018:

Record net revenues of $201.6 million, an increase of 14% versus 2017 GAAP net income of $15.5 million and diluted GAAP earnings per share of $1.30 Adjusted non-GAAP EBITDA of $84.4 million Adjusted non-GAAP diluted earnings per share of $5.07

For the fourth quarter 2018:

Record net revenues of $57.1 million, an increase of 21% versus 2017 GAAP net income of $5.4 million and diluted GAAP earnings per share of $0.46 Adjusted non-GAAP EBITDA of $22.2 million... More